The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy

• In-bore biopsy detects cancer in 40% men with negative software MR targeted biopsy. • Clinically significant cancer was missed by software MR targeted biopsy in 25%. • In-bore biopsy should be considered notably in men with enlarged prostates.